AGP Executive Report
Last update: 12 hours agoBiotech Breakthrough: Enhertu has just won new U.S. FDA approvals for two additional uses in HER2-positive early breast cancer, expanding its role in both neoadjuvant and adjuvant treatment pathways. Health Security: Australia is moving fast on a hantavirus scare, with six passengers from the MV Hondius landing in Perth for a quarantine expected to last at least three weeks. Telecom & Cost of Living: Starlink is lifting prices in the U.S. and elsewhere, adding $5–$10 a month for key plans from mid-June, with one Roam tier unchanged. Geopolitics: Trump’s China summit is being framed as a bust on Iran—China is still buying Iranian oil, and no joint plan for the Strait of Hormuz emerged. Policy & Industry: India is preparing a manufacturing push by targeting nearly 100 products to cut import dependence, alongside faster investment approvals and more trade deals. Sports & Culture: Fiji Drua co-captain Temo Mayanavanua admits they weren’t “urgent enough” in key moments after a loss to the Waratahs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
